Academic Foundation Programme, Nottingham University Hospitals NHS Trust, Nottingham, UK, Nottingham, UK
King's Technology Evaluation Centre, London Institute of Healthcare Engineering, School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Evid Based Ment Health. 2021 May;24(2):62-69. doi: 10.1136/ebmental-2020-300151. Epub 2020 Dec 21.
Currently, there is no accepted system for the classification of psychotherapies for application within systematic reviews. The creation of anuncomplicated, understandable and practical classification system is neccessary for conducting reliable systematic reviews.
To devise a system for classification of psychotherapy interventions-for use, initially, in systematic reviews.
Cochrane Schizophrenia's Register used as the source of randomised controlled trial. After being piloted and refined at least twice, finally we applied it to all relevant trials within the register. Basic statistical data already held within the register were extracted and used to calculate the distribution of schizophrenia research by form of psychotherapy.
The final classification system consisted of six definable broad 'boughs' two of which were further subdivided into 'branches'. The taxonomy accommodated all psychotherapy interventions described in the register. Of the initial 1645 intervention categories within the register, after careful recoding, 539 (33%) were psychotherapies (234 coded as 'Thought/Action' (cognitive & behavioural)-1495 studies; 135 'Cognitive Functioning'-652 studies; 113 'Social'-684 studies; 55 'Humanistic'-272 studies; 23 'Psychoanalytic/dynamic'-40 studies; and 63 'Other'-387 studies). For people with schizophrenia, across categories, the average size of psychotherapy trial is small (107) but there are notable and important exceptions.
We reported a practical method for categorising psychotherapy interventions in evaluative studies with applications beyond schizophrenia. A move towards consensus on the classification and reporting of psychotherapies is needed.
This classification can aid clinicians, clinical practice guideline developers, and evidence synthesis experts to recognise and compare the interventions from same or different classes.
目前，尚无被广泛接受的精神治疗分类系统可用于系统综述。为了进行可靠的系统综述，有必要建立一个简单、易懂且实用的分类系统。
设计一种精神治疗干预分类系统，最初用于系统综述。
以 Cochrane 精神分裂症注册库作为随机对照试验的来源。在经过至少两次试行和完善后，最终将其应用于注册库中所有相关试验。从注册库中提取并使用基本统计数据来计算精神分裂症研究中各种形式的精神治疗分布情况。
最终的分类系统由六个可定义的广泛“分支”组成，其中两个进一步细分为“分支”。该分类法涵盖了注册库中描述的所有精神治疗干预措施。在注册库中最初的 1645 个干预类别中，经过仔细重新编码，有 539 个（33%）是精神治疗（234 个被编码为“思维/行动”（认知和行为）-1495 项研究；135 个“认知功能”-652 项研究；113 个“社会”-684 项研究；55 个“人本主义”-272 项研究；23 个“精神分析/动力”-40 项研究；63 个“其他”-387 项研究）。对于精神分裂症患者，跨类别来看，精神治疗试验的平均规模较小（107 项），但也有显著和重要的例外。
我们报告了一种在评估研究中对精神治疗干预进行分类的实用方法，其应用范围超出了精神分裂症。需要就精神治疗的分类和报告达成共识。
该分类可帮助临床医生、临床实践指南制定者和证据综合专家识别和比较来自同一类别或不同类别的干预措施。
